XML 51 R40.htm IDEA: XBRL DOCUMENT
v3.23.3

ACQUISITIONS - Narrative (Details) - Spectrum Pharmaceuticals, Inc. - USD ($) $ / shares in Units, $ in Millions |  | 3 Months Ended | 9 Months Ended |  |
--- | --- | --- | --- | --- | ---
Jul. 31, 2023 | Sep. 30, 2023 | Sep. 30, 2023 | Dec. 31, 2025 | Dec. 31, 2024
Business Acquisition [Line Items] |  |  |  |  |
Business acquisition, fixed exchange ratio | $ 0.1783 |  |  |  |
Business acquisition, contingent consideration, per share, maximum (in dollars per share) | $ 0.20 |  |  |  |
Business combination, contingent consideration liability, number of shares (in shares) | 223,397 |  |  |  |
Business acquisition, contingent consideration, per share (in dollars per share) | $ 0.0176 |  |  |  |
Acquired finite-lived intangible assets, useful life | 10 years |  |  |  |
Acquisition costs related to the transaction |  | $ 2.7 | $ 8.5 |  |
ROLVEDON |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business combination, contingent consideration arrangements, range of outcomes, value, high | $ 44.7 |  |  |  |
ROLVEDON | Forecast |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business acquisition, contingent consideration, per share, maximum (in dollars per share) |  |  |  | $ 0.10 | $ 0.10
Business combination, contingent consideration arrangements, range of outcomes, value, high |  |  |  | $ 225.0 | $ 175.0

X
- Definition Business Acquisition, Contingent Consideration, Per Share + References No definition available. + Details
Name: | asrt_BusinessAcquisitionContingentConsiderationPerShare
Namespace Prefix: | asrt_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Acquisition, Contingent Consideration, Per Share, Maximum + References No definition available. + Details
Name: | asrt_BusinessAcquisitionContingentConsiderationPerShareMaximum
Namespace Prefix: | asrt_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Acquisition, Fixed Exchange Ratio + References No definition available. + Details
Name: | asrt_BusinessAcquisitionFixedExchangeRatio
Namespace Prefix: | asrt_
Data Type: | dtr-types1:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, Contingent Consideration Liability, Number of Shares + References No definition available. + Details
Name: | asrt_BusinessCombinationContingentConsiderationLiabilityNumberOfShares
Namespace Prefix: | asrt_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479405/805-10-25-23 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=asrt_SpectrumPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=asrt_RolvedonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |